Advertisement

Topics

Mentor Capital Initiates Discussions for Potential Merger

13:14 EDT 28 Sep 2017 | PR Newswire

SAN DIEGO, Aug. 18, 2011 /PRNewswire/ -- Mentor Capital, Inc. (OTC Markets: MNTR) announced today that confidential discussions have been initiated that could lead to a merger, acquisition or very significant investment with a medically related entity.  Mentor Capital's role in this transaction is to provide up to $100 Million in equity funding to support the growth and acquisition interests of the medical company.

Additional shareholder communication will be forthcoming to report on the progress of any negotiations in the transaction process.  

Mentor Capital has focused its efforts on providing acquisition or investment funding for leading-edge cancer fighting companies as detailed on the Mentor Capital website.

Forward Looking Statements, Safe Harbor and Risk Descriptions are Incorporated by Reference from the MNTR Company Web Site above.

For further information contact:

Chester Billingsley, CEO
Mentor Capital, Inc.
(760) 788 - 4700

SOURCE Mentor Capital, Inc.

NEXT ARTICLE

More From BioPortfolio on "Mentor Capital Initiates Discussions for Potential Merger"

Quick Search
Advertisement
 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...